Biomarkers for the lung cancer diagnosis and their advances in proteomics.
Explore this paper's citation graph
Summary
What the cancer biomarker discovery is for, various types of lung cancer biomarkers discovered at present and predicted future advance in lung tumour biomarkers discovery with proteomics technology are described.
- Type
- review
- Published
- 2008-09-30
- Cited by
- 163
- References
- 119
- Access
- Open access
- OpenAlex
- https://openalex.org/W1964064441
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:13967801
Keywords
Biomarker discovery, Biomarker, Proteomics, Lung cancer, Medicine
References
- Proteomic Strategies and their Application in Cancer Research
- Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer.
- Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis.
- Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
- Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancer
- Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.
- Proteomic strategies for biomarker identification: progress and challenges.
- CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group.
- Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
- Tumor markers in detection of lung cancer.
- ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
- Clinical significance of ras oncogene activation in human lung cancer.
- Use of tumor markers in lung cancer.
- Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer.
- Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.
- Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
- Cancer Statistics, 2006
- Translational studies for target-based drugs
- Cancer BiomarkersAn Invitation to the Table
- Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer.
Cited by
- Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma
- Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study.
- Hyphenated and unconventional methods for searching volatile cancer biomarkers
- Differentially expressed and activated proteins associated with non small cell lung cancer tissues
- Analysis of tumor markers in cytological fluid obtained from computed tomography–guided needle aspiration biopsies for the diagnosis of ground‐glass opacity pulmonary lesions
- Le secretome, un modèle adapté à l'étude des protéines sécrétées par les tumeurs. Application à l'analyse du rôle joué par p53 sur la sécrétion de protéines par des cellules du cancer du poumon.
- Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma
- Development of Conductive Nanocomposite Sensors for Anticipated Diagnostic of Diseases
- [Detection of markers for lymph nodes metastasis in lung cancer.].
- Correlation of a Serological Proteome and Lung Cancer Prognosis
- Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer.
- Topoisomerase-I PS506 as a Dual Function Cancer Biomarker
- Targeting of hepatocellular carcinoma with glypican‐3‐targeting peptide ligand
- Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
- Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression.
- Baseline Plasma Proteomic Analysis to Identify Biomarkers that Predict Radiation-Induced Lung Toxicity in Patients Receiving Radiation for Non-small Cell Lung Cancer
- Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non-small-cell lung cancer.
- An Improved Protocol for N-Glycosylation Analysis of Gel-Separated Sialylated Glycoproteins by MALDI-TOF/TOF
- Lung Cancer Proteomics: Recent Advances in Biomarker Discovery
- SERS tags-based novel monodispersed hollow gold nanospheres for highly sensitive immunoassay of CEA
Related papers
- Protein arrays for biomarker discovery in lupus
- Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.
- A Tool for Biomarker Discovery in the Urinary Proteome: A Manually Curated Human and Animal Urine Protein Biomarker Database*
- Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
- What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.
- Discovery and application of protein biomarkers for ovarian cancer
- Abstract 1703: Discovery and validation of 20 novel breast cancer methylation biomarkers: A new workflow for methylation biomarker development